상세 보기
Trastuzumab deruxtecan (T-DXd) plus pertuzumab (P) vs taxane plus trastuzumab plus pertuzumab (THP) for first-line treatment of Asian patients (pts) with HER2+advanced/ metastatic breast cancer (a/mBC): A DESTINY-Breast09 analysis
- Jiang, Z.;
- Park, Y. H.;
- Toi, M.;
- Tolaney, S. M.;
- Chae, Y. S.;
- 외 10명
Citations
WEB OF SCIENCE
1- 제목
- Trastuzumab deruxtecan (T-DXd) plus pertuzumab (P) vs taxane plus trastuzumab plus pertuzumab (THP) for first-line treatment of Asian patients (pts) with HER2+advanced/ metastatic breast cancer (a/mBC): A DESTINY-Breast09 analysis
- 저자
- Jiang, Z.; Park, Y. H.; Toi, M.; Tolaney, S. M.; Chae, Y. S.; Im, S-a.; Chen, W.; Huang, C-S.; Wang, H. C.; Yamashita, T.; Takano, T.; Darilay, A.; Huang, D.; Zeng, A.; Loibl, S.
- 발행일
- 2025-12
- 유형
- Meeting Abstract
- 권
- 36
- 언어
- ENG
- 출판사
- ELSEVIER
- 발행국가
- 네덜란드
- ISSN
- E 1569-8041
P 0923-7534